top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li
Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li
Autore Li Jie Jack
Pubbl/distr/stampa Oxford ; ; New York : , : Oxford University Press, , [2014]
Descrizione fisica 1 online resource (238 p.)
Disciplina 338.4/76151
Collana Oxford scholarship online
Soggetto topico Drugs - United States
Pharmaceutical industry - United States - History
Soggetto genere / forma Electronic books.
ISBN 0-19-756301-5
0-19-991192-4
0-19-990904-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Machine generated contents note: -- Table of Contents Chapter 1 Before the Age of Blockbuster Drugs Chapter 2 The Beginning of an Era - The First Blockbuster Drug Tagamet Chapter 3 More Blockbuster Drugs for Ulcer Chapter 4 Antihistamines as Allergy Medicines Chapter 5 Blood Thinners, From Heparin to Plavix Chapter 6 Conquest of Pain--Analgesics: from Morphine to Lyrica Chapter 7 Lessons Bibliography Appendix Index.
Record Nr. UNINA-9910453771703321
Li Jie Jack  
Oxford ; ; New York : , : Oxford University Press, , [2014]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li
Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li
Autore Li Jie Jack
Pubbl/distr/stampa Oxford ; ; New York : , : Oxford University Press, , [2014]
Descrizione fisica 1 online resource (238 p.)
Disciplina 338.4/76151
Collana Oxford scholarship online
Soggetto topico Drugs - United States
Pharmaceutical industry - United States - History
ISBN 0-19-756301-5
0-19-991192-4
0-19-990904-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Machine generated contents note: -- Table of Contents Chapter 1 Before the Age of Blockbuster Drugs Chapter 2 The Beginning of an Era - The First Blockbuster Drug Tagamet Chapter 3 More Blockbuster Drugs for Ulcer Chapter 4 Antihistamines as Allergy Medicines Chapter 5 Blood Thinners, From Heparin to Plavix Chapter 6 Conquest of Pain--Analgesics: from Morphine to Lyrica Chapter 7 Lessons Bibliography Appendix Index.
Record Nr. UNINA-9910790780603321
Li Jie Jack  
Oxford ; ; New York : , : Oxford University Press, , [2014]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li
Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li
Autore Li Jie Jack
Edizione [1st ed.]
Pubbl/distr/stampa Oxford ; ; New York : , : Oxford University Press, , [2014]
Descrizione fisica 1 online resource (238 p.)
Disciplina 338.4/76151
Collana Oxford scholarship online
Soggetto topico Drugs - United States
Pharmaceutical industry - United States - History
ISBN 0-19-756301-5
0-19-991192-4
0-19-990904-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Machine generated contents note: -- Table of Contents Chapter 1 Before the Age of Blockbuster Drugs Chapter 2 The Beginning of an Era - The First Blockbuster Drug Tagamet Chapter 3 More Blockbuster Drugs for Ulcer Chapter 4 Antihistamines as Allergy Medicines Chapter 5 Blood Thinners, From Heparin to Plavix Chapter 6 Conquest of Pain--Analgesics: from Morphine to Lyrica Chapter 7 Lessons Bibliography Appendix Index.
Record Nr. UNINA-9910806804503321
Li Jie Jack  
Oxford ; ; New York : , : Oxford University Press, , [2014]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Autore Mellon Jim
Pubbl/distr/stampa Chichester, West Sussex, U.K., : Wiley, 2012
Descrizione fisica 1 online resource (362 p.)
Disciplina 338.4/76151
Altri autori (Persone) ChalabiAl
Soggetto topico Biotechnology industries - Finance
Pharmaceutical industry - Finance
Biotechnology industries
Pharmaceutical industry
Investments
Soggetto genere / forma Electronic books.
ISBN 1-119-96937-9
1-280-67915-8
9786613656087
1-119-96936-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease
ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home?
ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing
Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index
Record Nr. UNINA-9910461624903321
Mellon Jim  
Chichester, West Sussex, U.K., : Wiley, 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Autore Mellon Jim
Pubbl/distr/stampa Chichester, West Sussex, U.K., : Wiley, 2012
Descrizione fisica 1 online resource (362 p.)
Disciplina 338.4/76151
Altri autori (Persone) ChalabiAl
Soggetto topico Biotechnology industries - Finance
Pharmaceutical industry - Finance
Biotechnology industries
Pharmaceutical industry
Investments
ISBN 1-119-96937-9
1-280-67915-8
9786613656087
1-119-96936-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease
ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home?
ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing
Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index
Record Nr. UNINA-9910790277003321
Mellon Jim  
Chichester, West Sussex, U.K., : Wiley, 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cracking the code : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Cracking the code : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Autore Mellon Jim
Edizione [1st ed.]
Pubbl/distr/stampa Chichester, West Sussex, U.K., : Wiley, 2012
Descrizione fisica 1 online resource (362 p.)
Disciplina 338.4/76151
Altri autori (Persone) ChalabiAl
Soggetto topico Biotechnology industries - Finance
Pharmaceutical industry - Finance
Biotechnology industries
Pharmaceutical industry
Investments
ISBN 1-119-96937-9
1-280-67915-8
9786613656087
1-119-96936-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease
ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home?
ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing
Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index
Record Nr. UNINA-9910825483003321
Mellon Jim  
Chichester, West Sussex, U.K., : Wiley, 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Devalued and distrusted [[electronic resource] ] : can the pharmaceutical industry restore its broken image? / / John L. LaMattina
Devalued and distrusted [[electronic resource] ] : can the pharmaceutical industry restore its broken image? / / John L. LaMattina
Autore LaMattina John L
Pubbl/distr/stampa Hoboken, N.J., : Wiley, 2013
Descrizione fisica 1 online resource (137 p.)
Disciplina 338.4/76151
Soggetto topico Pharmaceutical industry - Corrupt practices
ISBN 1-118-51132-8
1-283-91742-4
1-118-51129-8
Classificazione MED071000
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Machine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts.
Record Nr. UNINA-9910141533103321
LaMattina John L  
Hoboken, N.J., : Wiley, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Devalued and distrusted : can the pharmaceutical industry restore its broken image? / / John L. LaMattina
Devalued and distrusted : can the pharmaceutical industry restore its broken image? / / John L. LaMattina
Autore LaMattina John L
Edizione [1st ed.]
Pubbl/distr/stampa Hoboken, N.J., : Wiley, 2013
Descrizione fisica 1 online resource (137 p.)
Disciplina 338.4/76151
Soggetto topico Pharmaceutical industry - Corrupt practices
ISBN 1-118-51132-8
1-283-91742-4
1-118-51129-8
Classificazione MED071000
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Machine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts.
Record Nr. UNINA-9910824681403321
LaMattina John L  
Hoboken, N.J., : Wiley, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug compounding pharmacies : risk and oversight issues / / Seth Sharpe, editor
Drug compounding pharmacies : risk and oversight issues / / Seth Sharpe, editor
Pubbl/distr/stampa [Hauppauge] New York : , : Nova Publishers, , [2013]
Descrizione fisica 1 online resource (184 pages)
Disciplina 338.4/76151
Collana Pharmacology, research, safety testing and regulation
Public health in the 21st century
Soggetto topico Pharmaceutical technology - Standards
Pharmaceutical industry - United States - Quality control
Products liability - Drugs - United States
ISBN 1-62808-177-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910151722103321
[Hauppauge] New York : , : Nova Publishers, , [2013]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug discovery today Therapeutic strategies
Drug discovery today Therapeutic strategies
Pubbl/distr/stampa [Amsterdam] ; ; [New York, NY], : Elsevier, ©2004-[2013]
Descrizione fisica 1 online resource
Disciplina 338.4/76151
Soggetto topico Pharmaceutical industry
Drug development
Drugs - Design
Biopharmaceutics
Clinical pharmacology
Drug Therapy
Drug Design
Soggetto genere / forma Periodicals.
Soggetto non controllato Industries
ISSN 1740-6773
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Altri titoli varianti Therapeutic strategies
Record Nr. UNISA-996216406303316
[Amsterdam] ; ; [New York, NY], : Elsevier, ©2004-[2013]
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui